Form 4: 89bio CEO Rohan Palekar Reports Stock Transaction
SEC Form 4 Filing
Rohan Palekar, CEO of 89bio, Inc., reports disposition of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On February 17, 2025, Rohan Palekar, the CEO of 89bio, Inc. (ETNB), disposed of 3,249 shares of common stock to cover tax withholding obligations.
- The shares were withheld from the vesting of restricted stock units.
- The transaction price was $10.57 per share.
- Following the transaction, Palekar beneficially owns 862,240 shares of 89bio, Inc.
- This includes 797 shares acquired under the Issuer's 2019 Employee Stock Purchase Plan on December 31, 2024.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reflects a standard transaction for tax purposes and doesn't inherently indicate positive or negative performance for the company.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives regarding their holdings in the company's stock.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine sale of shares to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| December 31, 2024 | Reporting Person acquired 797 shares under the Issuer's 2019 Employee Stock Purchase Plan |
| 02/17/2025 | Date of transaction where 3,249 shares were disposed of to cover tax obligations. |
| 02/19/2025 | Date of report filing. |
Keywords
Form 4, 89bio, ETNB, Rohan Palekar, stock transaction, CEO, insider trading, restricted stock units, tax withholding, Employee Stock Purchase Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.